HCA Healthcare Inc
HCA472.070USD
-6.950-1.45%
Handelsschluss 01/09, 16:00（ET）Kurse um 15 Minuten verzögert
108.50BMarktkapitalisierung
18.04KGV TTM
mehr Informationen über HCA Healthcare Inc Unternehmen
HCA Healthcare, Inc. is a health care services company. It owns, manages or operates hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals and 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.
HCA Healthcare Inc Informationen
BörsenkürzelHCA
Name des UnternehmensHCA Healthcare Inc
IPO-datumDec 28, 2010
CEOHazen (Samuel N)
Anzahl der mitarbeiter226000
WertpapierartOrdinary Share
GeschäftsjahresendeDec 28
AddresseOne Park Plaza
StadtNASHVILLE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl37203
Telefon16153449551
Websitehttps://hcahealthcare.com/
BörsenkürzelHCA
IPO-datumDec 28, 2010
CEOHazen (Samuel N)
Führungskräfte von HCA Healthcare Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Samuel N. (Sam) Hazen
Mr. Samuel N. (Sam) Hazen
Chief Executive Officer, Director
Chief Executive Officer, Director
1.35M
-14830.00%
Mr. Jon Mark Foster
Mr. Jon Mark Foster
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
150.39K
-16778.00%
Dr. Michael S. Cuffe, M.D.
Dr. Michael S. Cuffe, M.D.
Executive Vice President, Chief Clinical Officer
Executive Vice President, Chief Clinical Officer
31.43K
--
Mr. Robert Jay (Bob) Dennis
Mr. Robert Jay (Bob) Dennis
Independent Director
Independent Director
26.60K
+1026.00%
Dr. Wayne Joseph Riley, M.D.
Dr. Wayne Joseph Riley, M.D.
Independent Director
Independent Director
14.52K
+645.00%
Mr. Michael W. Michelson, J.D.
Mr. Michael W. Michelson, J.D.
Independent Director
Independent Director
11.65K
+1173.00%
Dr. Sammie S. Mosier
Dr. Sammie S. Mosier
Senior Vice President, Chief Nurse Executive
Senior Vice President, Chief Nurse Executive
11.11K
+715.00%
Ms. Andrea B. Smith
Ms. Andrea B. Smith
Independent Director
Independent Director
4.24K
+645.00%
Mr. Hugh F. Johnston
Mr. Hugh F. Johnston
Independent Director
Independent Director
3.67K
+1026.00%
Mr. Thomas F. Frist, III
Mr. Thomas F. Frist, III
Chairman of the Board
Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Samuel N. (Sam) Hazen
Mr. Samuel N. (Sam) Hazen
Chief Executive Officer, Director
Chief Executive Officer, Director
1.35M
-14830.00%
Mr. Jon Mark Foster
Mr. Jon Mark Foster
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
150.39K
-16778.00%
Dr. Michael S. Cuffe, M.D.
Dr. Michael S. Cuffe, M.D.
Executive Vice President, Chief Clinical Officer
Executive Vice President, Chief Clinical Officer
31.43K
--
Mr. Robert Jay (Bob) Dennis
Mr. Robert Jay (Bob) Dennis
Independent Director
Independent Director
26.60K
+1026.00%
Dr. Wayne Joseph Riley, M.D.
Dr. Wayne Joseph Riley, M.D.
Independent Director
Independent Director
14.52K
+645.00%
Mr. Michael W. Michelson, J.D.
Mr. Michael W. Michelson, J.D.
Independent Director
Independent Director
11.65K
+1173.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
American group
6.69B
34.90%
Atlantic Group
6.14B
32.05%
National group
5.53B
28.83%
Corporate and other
806.00M
4.21%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Hercules Holding II
30.20%
The Vanguard Group, Inc.
6.49%
Sanders Capital, LLC
4.68%
BlackRock Institutional Trust Company, N.A.
3.40%
State Street Investment Management (US)
3.28%
Andere
51.95%
Aktionäre
Aktionäre
Anteil
Hercules Holding II
30.20%
The Vanguard Group, Inc.
6.49%
Sanders Capital, LLC
4.68%
BlackRock Institutional Trust Company, N.A.
3.40%
State Street Investment Management (US)
3.28%
Andere
51.95%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
34.35%
Corporation
30.20%
Investment Advisor/Hedge Fund
19.36%
Pension Fund
2.11%
Hedge Fund
1.75%
Bank and Trust
1.39%
Sovereign Wealth Fund
1.39%
Research Firm
1.32%
Individual Investor
1.16%
Andere
6.98%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
2307
141.21M
61.88%
-14.09M
2025Q3
2301
148.00M
64.85%
-12.53M
2025Q2
2310
229.16M
97.93%
-11.11M
2025Q1
2325
230.33M
95.69%
-9.90M
2024Q4
2258
234.95M
94.56%
-4.46M
2024Q3
2192
234.05M
91.76%
-11.07M
2024Q2
2126
239.45M
92.36%
-7.50M
2024Q1
2117
240.61M
92.66%
-8.64M
2023Q4
2082
243.30M
92.89%
-5.45M
2023Q3
2034
242.79M
88.27%
-10.13M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Hercules Holding II
68.91M
30.2%
--
--
Feb 24, 2025
The Vanguard Group, Inc.
14.80M
6.49%
-581.67K
-3.78%
Sep 30, 2025
Sanders Capital, LLC
10.68M
4.68%
-426.92K
-3.85%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
7.76M
3.4%
-305.28K
-3.79%
Sep 30, 2025
State Street Investment Management (US)
7.49M
3.28%
-466.06K
-5.86%
Sep 30, 2025
Capital World Investors
4.96M
2.17%
+179.44K
+3.75%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
3.92M
1.72%
-290.38K
-6.90%
Sep 30, 2025
Wellington Management Company, LLP
3.88M
1.7%
-230.12K
-5.60%
Sep 30, 2025
Geode Capital Management, L.L.C.
3.65M
1.6%
-147.76K
-3.89%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
3.01M
1.32%
+208.56K
+7.45%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares U.S. Healthcare Providers ETF
5%
God Bless America ETF
4.62%
Argent Mid Cap ETF
4.33%
Invesco Dynamic Buyback Achievers ETF
3.87%
LeaderShares AlphaFactor Tactical Focused ETF
3.11%
First Eagle Global Equity ETF
2.83%
JPMorgan Equity Focus Fund
2.74%
State Street SPDR S&P Health Care Services ETF
2.38%
Strategas Macro Momentum ETF
2.34%
Brandes US Value ETF
2.26%
Mehr Anzeigen
iShares U.S. Healthcare Providers ETF
Anteil5%
God Bless America ETF
Anteil4.62%
Argent Mid Cap ETF
Anteil4.33%
Invesco Dynamic Buyback Achievers ETF
Anteil3.87%
LeaderShares AlphaFactor Tactical Focused ETF
Anteil3.11%
First Eagle Global Equity ETF
Anteil2.83%
JPMorgan Equity Focus Fund
Anteil2.74%
State Street SPDR S&P Health Care Services ETF
Anteil2.38%
Strategas Macro Momentum ETF
Anteil2.34%
Brandes US Value ETF
Anteil2.26%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
2.63B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Oct 24, 2025
HCA.NB Final Cash Dividend of gross USD 0.72 paid on Dec 29, 2025 going ex on Dec 15, 2025
Dec 15, 2025
Dec 29, 2025
Dec 15, 2025
Jul 25, 2025
HCA.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 30, 2025 going ex on Sep 16, 2025
Sep 16, 2025
Sep 30, 2025
Sep 16, 2025
Apr 25, 2025
HCA.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 30, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jun 30, 2025
Jun 16, 2025
Jan 24, 2025
HCA.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 31, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Mar 31, 2025
Mar 17, 2025
Oct 25, 2024
HCA.NB Final Cash Dividend of gross USD 0.66 paid on Dec 27, 2024 going ex on Dec 13, 2024
Dec 13, 2024
Dec 27, 2024
Dec 13, 2024
Jul 23, 2024
HCA.NB Interim Cash Dividend of gross USD 0.66 paid on Sep 30, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Sep 30, 2024
Sep 16, 2024
Apr 26, 2024
HCA.NB Interim Cash Dividend of gross USD 0.66 paid on Jun 28, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jun 28, 2024
Jun 14, 2024
Jan 30, 2024
HCA.NB Interim Cash Dividend of gross USD 0.66 paid on Mar 29, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Mar 29, 2024
Mar 14, 2024
Oct 24, 2023
HCA.NB Final Cash Dividend of gross USD 0.6 paid on Dec 28, 2023 going ex on Dec 13, 2023
Dec 14, 2023
Dec 28, 2023
Dec 13, 2023
Jul 27, 2023
HCA.NB Interim Cash Dividend of gross USD 0.6 paid on Sep 29, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Sep 29, 2023
Sep 14, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von HCA Healthcare Inc?
Die fünf größten Anteilseigner von HCA Healthcare Inc sind:
Hercules Holding II hält 68.91M Aktien, was 30.20% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 14.80M Aktien, was 6.49% der Gesamtaktien entspricht.
Sanders Capital, LLC hält 10.68M Aktien, was 4.68% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 7.76M Aktien, was 3.40% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 7.49M Aktien, was 3.28% der Gesamtaktien entspricht.
Hercules Holding II hält 68.91M Aktien, was 30.20% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 14.80M Aktien, was 6.49% der Gesamtaktien entspricht.
Sanders Capital, LLC hält 10.68M Aktien, was 4.68% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 7.76M Aktien, was 3.40% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 7.49M Aktien, was 3.28% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von HCA Healthcare Inc?
Die drei wichtigsten Anteilseigner-Typen von HCA Healthcare Inc sind:
Hercules Holding II
The Vanguard Group, Inc.
Sanders Capital, LLC
Hercules Holding II
The Vanguard Group, Inc.
Sanders Capital, LLC
Wie viele Institutionen halten Anteile an HCA Healthcare Inc (HCA)?
Mit Stand vom 2025Q4 halten 2307 Institutionen Anteile an HCA Healthcare Inc, mit einem Gesamtmarktwert von etwa 141.21M, was 61.88% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -2.97% gestiegen.
Was ist die größte Einnahmequelle von HCA Healthcare Inc?
Am FY2025Q3 erzielte das Geschäft mit -- für HCA Healthcare Inc den höchsten Umsatz in Höhe von --, was --% des Gesamtumsatzes entspricht.
